Ainos (OTCMKTS:AIMD) Trading Down 4.4% – Here’s Why

Shares of Ainos, Inc. (OTCMKTS:AIMD) traded down 4.4% during trading on Thursday . The stock traded as low as $1.91 and last traded at $1.95. 55,657 shares changed hands during trading, a decline of 96% from the average session volume of 1,581,776 shares. The stock had previously closed at $2.04.

Ainos Stock Performance

The stock’s fifty day simple moving average is $2.00 and its two-hundred day simple moving average is $2.82. The company has a market cap of $9.19 million, a price-to-earnings ratio of -2.20 and a beta of 2.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.